FDA Inspection 902520 — Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated — FEI 1000513211

The FDA completed an inspection of Vertex Pharmaceuticals Incorporated on Oct 16, 2014 in Boston, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Oct 16, 2014
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Boston, MA (United States)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures
673021 CFR 314.80(b)Failure to develop written procedures
673221 CFR 314.80(c)(1)(i)Late submission of 15-day report

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.